The European Alliance for Transformative Therapies is a multi-stakeholder coalition open to any stakeholders active in the field of transformative therapies. A Steering Group with a balanced representation of the members facilitates the work of the Alliance.

The TRANSFORM MEP Interest Group comprises cross-party Members of the European Parliament. Three Co-Chairs lead the initiative and pursue dialogue with stakeholders and decision-makers.

The TRANSFORM Secretariat provides organisational support to both the European Alliance for Transformative Therapies and the TRANSFORM MEP Interest Group. Its work is enabled by funding from the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and its members.

@TRANSFORM_CGT on Twitter Follow us →

Interesting event @alliancerm today! With the EU Pharma legislation review, the new HTA Regulation and the EHDS, the EU has an opportunity to encourage innovation & ensure that ATMPs are a central part of the EU’s healthcare landscape @Kympouropoulos @susanasolisp #MEPsforATMPs
29 November at 9:07pm
MEP @dieGamon endorses Recommendation 7️⃣ of the TRANSFORM MEP Charter, which calls for improved infrastructure and cross-border healthcare for ATMPs #MEPsforATMPs
22 November at 11:33am
Hear MEP @susanasolis outline Recommendation 6️⃣ of the TRANSFORM MEP Charter. Considering innovative access pathways for cell and gene therapies could help bring more ATMPs to #patients #MEPsforATMPs
17 November at 10:25am